Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Press release

Redeye: Serstech - Adjusting the lens

Serstech

Redeye provides an update of its estimates and valuation for Serstech following the Q1 2025 report and our quarterly presentation with the company. Quarterly performance was mostly in line with expectations, given the announced order intake, with sales at SEK19.9m compared to our estimate of SEK20.0m. Quarterly variations will likely remain significant for the company, and we encourage investors to maintain a long-term perspective. We have slightly lowered our near-term sales estimates and reduced our gross margin assumptions over the forecast period. Our fair value range has been slightly adjusted downward, and we await new order announcements to help close the gap to our Base Case.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments


Serstech - Adjusting the lens

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.